vivekanandkem Profile Banner
Vivekanand Sharma Profile
Vivekanand Sharma

@vivekanandkem

Followers
667
Following
5K
Media
15
Statuses
1K

Father to four furry babies/ Son/Brother/Husband/Amateur photographer/Surgical Oncologist. Primary interest-GI Oncology, MIS, Peritoneal surface, AI in Surg

India / UK
Joined October 2013
Don't wanna be here? Send us removal request.
@vivekanandkem
Vivekanand Sharma
1 day
RT @YouESCP: 🧐 Can we trust all guidelines?.So many recs—so little agreement. Join us in Paris for the Y-ESCP Pre-Congress Course on System….
0
14
0
@vivekanandkem
Vivekanand Sharma
15 days
RT @PSOGI_EC: The deadline for abstract submission is tonight!. ⏲️23.59 CET 🇪🇺. #PSOGI2025 #PSOGIBarcelona . ▶️ Submit your abstract .https….
0
4
0
@vivekanandkem
Vivekanand Sharma
20 days
For a disease deemed incurable once, to some Cytoreduction and HIPEC can bring #Rebirth. One belly-button less,.But full of life & all it has to offer. 💪. Such a meaningful logo ! Great work !.
@PMPSurvivor
Pseudomyxoma Survivor
23 days
Our logo may make more sense after reading this! #pseudomyxomasurvivor #pseudomyxomaperitonei #appendixcancer 😉
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
2
@vivekanandkem
Vivekanand Sharma
21 days
Tweet media one
0
818
0
@vivekanandkem
Vivekanand Sharma
21 days
RT @indepso: 🌟Celebrating 🇮🇳 #PSM ⭐️ @MVR_CANCON2025🌟. A conference of this scale would not have been possible without the vision and leade….
0
3
0
@vivekanandkem
Vivekanand Sharma
21 days
RT @indepso: ⭐️#RohitKumar- gave a wonderful lecture on the role and future of #PIPAC in #OvarianCa while #NinadKatdare discussed the same….
0
2
0
@vivekanandkem
Vivekanand Sharma
21 days
RT @indepso: ⭐️#AvanishSaklani – Moderated another great panel discussion on #PseudomyxomaPeritonei. ⭐️@DrVAChaudhari- shared insights from….
0
2
0
@vivekanandkem
Vivekanand Sharma
21 days
RT @indepso: The story doesn’t end here. Stay tuned for *Part 2*, to meet : . 🔹 The *rising stars* of PSM research in India, .🔹 e-Posters t….
0
3
0
@vivekanandkem
Vivekanand Sharma
25 days
RT @WiseOwl1730570: @DrLukeCraddock We need to say out aloud who is responsible for this mess. It starts with Tory politicians, NHS Manager….
0
2
0
@vivekanandkem
Vivekanand Sharma
30 days
RT @indepso: *Dr. Paul Sugarbaker @PSugarbaker * – A Masterclass in Academic Dedication!* 🎓 . At #MVRCCRI #CANCON2025, we witnessed somethi….
0
2
0
@vivekanandkem
Vivekanand Sharma
1 month
RT @indepso: In an era where networking can sometimes take precedence over academics, he reminded us what it means to prioritize #learning,….
0
1
0
@vivekanandkem
Vivekanand Sharma
1 month
RT @indepso: 🌟 @MVRCancerCentre #CANCON2025 – Where the West Met India in Peritoneal Oncology! 🌟. Just like Calicut once bridged the West….
0
8
0
@vivekanandkem
Vivekanand Sharma
1 month
RT @indepso: The stage is set for the MVR CANCON 2025 to begin !! . Video workshop by Dr. @PSugarbaker . Packed halls ready for the academi….
0
5
0
@vivekanandkem
Vivekanand Sharma
1 month
RT @drmgoel: Proud to have our lead Radiation Oncologist presenting Our POLCA GB - phase III trial #ASCO 2025. The first RCT on Gallbladde….
0
9
0
@vivekanandkem
Vivekanand Sharma
1 month
RT @PSOGI_EC: #ASCO25 American Society of Clinical Oncology (ASCO) .Congratulations to the investigators of #CAIRO-6 🎊 . Cytoreductive Surg….
0
16
0
@vivekanandkem
Vivekanand Sharma
2 months
RT @PSOGI_EC: #PSOGI2025.#PSOGIBarcelona.Final call: abstract submission deadline approaching!. 📅 June 1st at .⏲️ 23:59 (CET). The tim….
0
8
0
@vivekanandkem
Vivekanand Sharma
2 months
RT @MufaddalKazi: P-values rule research, but do they answer our questions?.Review @IASO_IJSOonline compares frequentist vs. Bayesian meta-….
0
10
0
@vivekanandkem
Vivekanand Sharma
2 months
RT @NiuSanford: I hadn't realized that CPS score for PDL1 expression is manually counted!. Pathologists look at a slide w at least 100 cell….
0
30
0